Balloon Angioplasty for In-Stent Restenosis Resulting in Carotid Stent Fracture: Literature Review of Stent-in-Stent Technique as a Viable Therapeutic Option

Naeem, Abdul-Haseeb; Alrumaihi, G; Namavarian, Amirpouyan; Sharma, Manas; Boulton, Melfort

doi:10.1016/j.wneu.2017.01.127

Cited by 4 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17 While these treatments effectively reduce the harm caused by AS, there is still room for improvement in optimizing their effectiveness. 18 For instance, drug treatments have certain shortcomings, such as a limited effective period, rapid drug clearance leading to a short action time, and inadequate targeting, 19 while PTCA is associated with challenges such as persistence, insufficient permeability, a high restenosis rate, and arterial wall hyperplasia. 20 In recent years, nanomedicine has made significant progress in the treatment and imaging of AS.…”

Section: ■ Introductionmentioning

confidence: 99%

“…Various treatments such as bare metal stents (BMS), stent balloons, drug-eluting stents (DES) embedded with antiproliferative drugs such as sirolimus or PTX, and fully bioabsorbable stents have been extensively utilized in PTCA . While these treatments effectively reduce the harm caused by AS, there is still room for improvement in optimizing their effectiveness . For instance, drug treatments have certain shortcomings, such as a limited effective period, rapid drug clearance leading to a short action time, and inadequate targeting, while PTCA is associated with challenges such as persistence, insufficient permeability, a high restenosis rate, and arterial wall hyperplasia …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Design and Fabrication of Environmentally Responsive Nanoparticles for the Diagnosis and Treatment of Atherosclerosis

Wang,

Lu,

Yin

et al. 2024

ACS Biomater. Sci. Eng.

View full text Add to dashboard Cite

Cardiovascular disease poses a significant threat to human health in today's society. A major contributor to cardiovascular disease is atherosclerosis (AS). The development of plaque in the affected areas involves a complex pathological environment, and the disease progresses rapidly. Nanotechnology, combined with emerging diagnostic and treatment methods, offers the potential for the management of this condition. This paper presents the latest advancements in environment-intelligent responsive controlled-release nanoparticles designed specifically for the pathological environment of AS, which includes characteristics such as low pH, high reactive oxygen species levels, high shear stress, and multienzymes. Additionally, the paper summarizes the applications and features of nanotechnology in interventional therapy for AS, including percutaneous transluminal coronary angioplasty and drug-eluting stents. Furthermore, the application of nanotechnology in the diagnosis of AS shows promising real-time, accurate, and continuous effects. Lastly, the paper explores the future prospects of nanotechnology, highlighting the tremendous potential in the diagnosis and treatment of atherosclerotic diseases, especially with the ongoing development in nano gas, quantum dots, and Metal−Organic Frameworks materials.

show abstract